Similar articles

• Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.

  Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, Breteler MM, Bautista LE, Sharma P, Whittaker JC, Smeeth L, Fowkes FG, Algra A, Shmeleva V, Szolnoki Z, Roest M, Linnebank M, Zacho J, Nalls MA, Singleton AB, Ferrucci L, Hardy J, Worrall BB, Rich SS, Matarin M, Norman PE, Flicker L, Almeida OP, van Bockxmeer FM, Shimokata H, Khaw KT, Wareham NJ, Bobak M, Sterne JA, Smith GD, Talmud PJ, van Duijn C, Humphries SE, Price JF, Ebrahim S, Lawlor DA, Hankey GJ, Meschia JF, Sandhu MS, Hingorani AD, Casas JP. Holmes MV, et al. Lancet. 2011 Aug 13;378(9791):584-94. doi: 10.1016/S0140-6736(11)60872-6. Epub 2011 Jul 29. Lancet. 2011. PMID: 21803414 Free PMC article.
• Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.

  Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, Li J, Fu J, Huang X, Cheng X, Wang B, Hou FF, Sun N, Cai Y. Zhao M, et al. Stroke. 2017 May;48(5):1183-1190. doi: 10.1161/STROKEAHA.116.015324. Epub 2017 Mar 30. Stroke. 2017. PMID: 28360116 Clinical Trial.
• Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.

  Ueland PM, Clarke R. Ueland PM, et al. Clin Chem. 2007 May;53(5):807-9. doi: 10.1373/clinchem.2007.085480. Clin Chem. 2007. PMID: 17468406 No abstract available.
• C(1) metabolism and CVD outcomes in older adults.

  McNulty H, Strain JJ, Pentieva K, Ward M. McNulty H, et al. Proc Nutr Soc. 2012 May;71(2):213-21. doi: 10.1017/S0029665111003387. Epub 2011 Dec 12. Proc Nutr Soc. 2012. PMID: 22152927 Review.
• Homocysteine, B-vitamins and CVD.

  McNulty H, Pentieva K, Hoey L, Ward M. McNulty H, et al. Proc Nutr Soc. 2008 May;67(2):232-7. doi: 10.1017/S0029665108007076. Proc Nutr Soc. 2008. PMID: 18412997 Review.